- Home
- ZYBT vs NXPLW Comparison
ZYBT vs NXPLW Comparison
Compare ZYBT & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYBT
- NXPLW
- Stock Information
- Founded
- ZYBT 2004
- NXPLW N/A
- Country
- ZYBT China
- NXPLW United States
- Employees
- ZYBT N/A
- NXPLW 166
- Industry
- ZYBT
- NXPLW Telecommunications Equipment
- Sector
- ZYBT
- NXPLW Telecommunications
- Exchange
- ZYBT NYSE
- NXPLW Nasdaq
- Market Cap
- ZYBT N/A
- NXPLW N/A
- IPO Year
- ZYBT 2025
- NXPLW N/A
- Fundamental
- Price
- ZYBT $10.06
- NXPLW N/A
- Analyst Decision
- ZYBT
- NXPLW
- Analyst Count
- ZYBT 0
- NXPLW 0
- Target Price
- ZYBT N/A
- NXPLW N/A
- AVG Volume (30 Days)
- ZYBT 555.0K
- NXPLW 6.4K
- Earning Date
- ZYBT 01-01-0001
- NXPLW 03-31-2025
- Dividend Yield
- ZYBT N/A
- NXPLW N/A
- EPS Growth
- ZYBT N/A
- NXPLW N/A
- EPS
- ZYBT 0.06
- NXPLW N/A
- Revenue
- ZYBT $26,111,272.00
- NXPLW $66,482,000.00
- Revenue This Year
- ZYBT N/A
- NXPLW N/A
- Revenue Next Year
- ZYBT N/A
- NXPLW N/A
- P/E Ratio
- ZYBT $164.56
- NXPLW N/A
- Revenue Growth
- ZYBT N/A
- NXPLW 179.89
- 52 Week Low
- ZYBT $3.50
- NXPLW $0.25
- 52 Week High
- ZYBT $10.42
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- ZYBT N/A
- NXPLW N/A
- Support Level
- ZYBT N/A
- NXPLW N/A
- Resistance Level
- ZYBT N/A
- NXPLW N/A
- Average True Range (ATR)
- ZYBT 0.00
- NXPLW 0.00
- MACD
- ZYBT 0.00
- NXPLW 0.00
- Stochastic Oscillator
- ZYBT 0.00
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.